Impact Factor 4.137 | CiteScore 4.28
More on impact ›

Correction ARTICLE

Front. Oncol., 11 May 2018 | https://doi.org/10.3389/fonc.2018.00150

Corrigendum: Fucosylated Antigens in Cancer: An Alliance Toward Tumor Progression, Metastasis, and Resistance to Chemotherapy

  • Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, Netherlands

A corrigendum on

Fucosylated Antigens in Cancer: An Alliance Toward Tumor Progression, Metastasis, and Resistance to Chemotherapy
Blanas A, Sahasrabudhe NM, Rodríguez E, van Kooyk Y, van Vliet SJ. Front Oncol (2018) 8:39. doi: 10.3389/fonc.2018.00039

We recently published our review with the title: “Fucosylated Antigens in Cancer: An Alliance Toward Tumor Progression, Metastasis, and Resistance to Chemotherapy” in Frontiers in Oncology.

However, we noticed that there is a mistake in the abstract of the article. Specifically, the abstract mentions “endothelial to mesenchymal transition” instead of “epithelial to mesenchymal transition.”

We are submitting this Corrigendum in order to clarify the error and apologize for any confusion by the readers.

The correct sentence should read: “Here, we review the relevance of tumor-overexpressed FUTs and their respective synthesized Lewis determinants in critical aspects associated with cancer progression, such as increased cell survival and proliferation, tissue invasion and metastasis, epithelial to mesenchymal transition, endothelial and immune cell interaction, angiogenesis, multidrug resistance, and cancer stemness.”

The original article has been updated.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Keywords: cancer, glycosylation, fucosylation, fucosyltransferases, Lewis antigens

Citation: Blanas A, Sahasrabudhe NM, Rodríguez E, van Kooyk Y and van Vliet SJ (2018) Corrigendum: Fucosylated Antigens in Cancer: An Alliance Toward Tumor Progression, Metastasis, and Resistance to Chemotherapy. Front. Oncol. 8:150. doi: 10.3389/fonc.2018.00150

Received: 16 April 2018; Accepted: 23 April 2018;
Published: 11 May 2018

Edited and Reviewed by: Leonardo Freire-de-Lima, Universidade Federal do Rio de Janeiro, Brazil

Copyright: © 2018 Blanas, Sahasrabudhe, Rodríguez, van Kooyk and van Vliet. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Sandra J. van Vliet, s.vanvliet@vumc.nl